OBESITY CONTRIBUTES TO SUBOPTIMAL PHYSICAL FUNCTION IN RHEUMATOID ARTHRITISANNALS OF THE RHEUMATIC DISEASESIF20.62017-06-010OAAI
I JUST WANT MY LIFE BACK: PHYSICAL FUNCTION AND FATIGUE ARE CRITICAL TARGETS FOR IMPROVING PARTICIPATION AND HRQL IN RHEUMATOID ARTHRITISANNALS OF THE RHEUMATIC DISEASESIF20.62017-06-010OAAI
Response to: Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by BoersANNALS OF THE RHEUMATIC DISEASESIF20.62016-10-011OAAI
HEMOGLOBIN IS A BETTER PREDICTOR FOR RADIOGRAPHIC PROGRESSION THAN DAS28 IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS-ANALYSIS FROM INTRAVENOUSLY ADMINISTERED GOLIMUMAB GO-FURTHER STUDYANNALS OF THE RHEUMATIC DISEASESIF20.62016-06-013PREAI
IS TREAT-TO-TARGET REALLY WORKING? A LONGITUDINAL ANALYSIS IN BIODAMANNALS OF THE RHEUMATIC DISEASESIF20.62016-06-011PREAI
IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES FOLLOWING 52 WEEKS OF TREATMENT WITH CERTOLIZUMAB PEGOL IN COMBINATION WITH METHOTREXATE IN DMARD-NAIVE PATIENTS WITH SEVERE, ACTIVE AND PROGRESSIVE RHEUMATOID ARTHRITIS: RESULTS FROM THE C-EARLY RANDOMIZED, DOUBLE-BLIND, CONTROLLED PHASE 3 STUDYVALUE IN HEALTHIF62015-11-012OAAI
MEASURING THE EFFECTIVENESS OF PATIENT EDUCATION FOR PATIENTS RECEIVING INJECTABLE BIOLOGIC MEDICATIONSANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-010PREAI
CLINICAL CHARACTERISTICS OF RA PATIENTS NEWLY PRESCRIBED TOFACITINIB CITRATE (TOFACITINIB) IN THE UNITED STATES AFTER FOOD AND DRUG ADMINISTRATION APPROVAL: RESULTS FROM THE CORRONA US RHEUMATOID ARTHRITIS REGISTRYANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-015PREAI
IL-17 LEVELS WITH VITAMIN D REPLETION IN RHEUAMTOID ARTHRITISANNALS OF THE RHEUMATIC DISEASESIF20.62014-06-010PREAI
EFFICACY AND SAFETY OF TABALUMAB, AN ANTI-B CELL ACTIVATING FACTOR MONOCLONAL ANTIBODY, IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAD AN INADEQUATE RESPONSE TO METHOTREXATE THERAPY: RESULTS FROM A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDYANNALS OF THE RHEUMATIC DISEASESIF20.62014-06-010PREAI
INTRAVENOUS GOLIMUMAB INHIBITS RADIOGRAPHIC PROGRESSION AND MAINTAINS CLINICAL EFFICACY AND SAFETY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY: 2-YEAR RESULTS OF A PHASE 3 TRIAL OF INTRAVENOUS GOLIMUMABANNALS OF THE RHEUMATIC DISEASESIF20.62014-06-010PREAI
HOW WELL DO GENERIC PROMIS FATIGUE MEASURES PERFORM IN RHEUMATOID ARTHRITIS?VALUE IN HEALTHIF62014-05-011OAAI
EARLY RA PATIENTS REPORTING A FLARE IDENTIFY MORE TENDER THAN SWOLLEN JOINTSANNALS OF THE RHEUMATIC DISEASESIF20.62012-06-010PREAI
PATIENT -REPORTED OUTCOMES IN THE IDIOPATHIC INFLAMMATORY MYOPATHIESANNALS OF THE RHEUMATIC DISEASESIF20.62012-06-010PREAI